Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-25 @ 4:04 AM
NCT ID:
NCT00548002
Eligibility Criteria:
Inclusion Criteria:
Adult patients with at least 1 blood culture positive for Staphylococcus aureus were included within 1 to 7 days of blood culture sampling.
Exclusion Criteria:
* age younger than 18 years
* imprisonment
* proven or suspected pregnancy
* breastfeeding, epilepsy
* another bacteremia during the previous 28 days
* polymicrobial bacteremia (\_\>3 microbes)
* history of allergy to any quinolone antibiotic
* previous tendinitis during fluoroquinolone therapy
* prior fluoroquinolone use for more than 5 days before randomization
* positive culture for Staphylococcus aureus only from a central intravenous catheter
* neutropenia (\<0.5 x 109/L) or failure to supply an informed consent
* patients with bacteremia due to methicillin-resistant S. aureus and a S. aureus strain resistant to any fluoroquinolone
* patients with meningitis at the time of randomization
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00548002
Study Brief:
Protocol Section:
NCT00548002